A Multicenter, Single-arm Clinical Study of the Efficacy and Safety of CSA in Combination With Avatrombopag for the Treatment of Primary Treatment of Severe Aplastic Anemia in the Elderly
Latest Information Update: 15 Jan 2024
At a glance
- Drugs Avatrombopag (Primary) ; Ciclosporin (Primary)
- Indications Aplastic anaemia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 12 Dec 2023 Results(n=10) presented at the 65th American Society of Hematology Annual Meeting and Exposition, concluding that the preliminary study of IST combined with avatrombopag for the treatment of elderly patients with V/SAA showed the potential of the combination to improve haematologic response rate and quality in elderly patients with AA, and it is well tolerated as well.
- 30 Jun 2022 New trial record